TAM
SYNH

Trillium Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Trillium Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-89,416
Closed -$3.51M – 228
2023
Q1 		$3.51M Buy
89,416
+4,664
+6% +$169K 0.1% 129
2022
Q4 		$3.11M Sell
84,752
-125,403
-60% -$4.96M 0.1% 138
2022
Q3 		$9.91M Buy
210,155
+1,024
+0.5% +$66.1K 0.32% 88
2022
Q2 		$15M Sell
209,131
-6,697
-3% -$490K 0.46% 79
2022
Q1 		$17.5M Sell
215,828
-3,008
-1% -$254K 0.46% 79
2021
Q4 		$22.5M Buy
218,836
+18,925
+9% +$1.82M 0.53% 70
2021
Q3 		$17.5M Buy
199,911
+14,457
+8% +$1.31M 0.46% 81
2021
Q2 		$16.6M Buy
185,454
+26,849
+17% +$2.27M 0.46% 78
2021
Q1 		$12M Buy
158,605
+113,281
+250% +$8.54M 0.38% 88
2020
Q4 		$3.09M Buy
45,324
+2,166
+5% +$135K 0.11% 124
2020
Q3 		$2.29M Sell
43,158
-18,294
-30% -$1.09M 0.1% 126
2020
Q2 		$3.58M Sell
61,452
-872
-1% -$46.9K 0.15% 114
2020
Q1 		$2.46M Buy
62,324
+16,635
+36% +$973K 0.13% 136
2019
Q4 		$2.72M Buy
45,689
+77
+0.2% +$4.14K 0.12% 145
2019
Q3 		$2.43M Buy
45,612
+57
+0.1% +$2.92K 0.11% 149
2019
Q2 		$2.33M Buy
45,555
+5,300
+13% +$247K 0.11% 153
2019
Q1 		$2.08M Buy
40,255
+1,483
+4% +$71.9K 0.11% 154
2018
Q4 		$1.53M Buy
38,772
+1,369
+4% +$63.6K 0.09% 164
2018
Q3 		$1.93M Buy
37,403
+1,257
+3% +$61.5K 0.1% 161
2018
Q2 		$1.7M Buy
36,146
+814
+2% +$33.7K 0.09% 167
2018
Q1 		$1.25M Sell
35,332
-235
-0.7% -$9.2K 0.07% 174
2017
Q4 		$1.55M Buy
35,567
+13,303
+60% +$622K 0.09% 164
2017
Q3 		$1.16M Buy
22,264
+268
+1% +$14.9K 0.07% 171
2017
Q2 		$1.29M Buy
21,996
+1,335
+6% +$69.4K 0.08% 168
2017
Q1 		$947K Buy
+20,661
New +$1.03M 0.06% 170

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Trillium Asset Management's SYNH Position: Q2 2023 in Review

Trillium Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 89,416 shares — an estimated $3.51M sold.

Trillium Asset Management first reported a position in SYNH in Q1 2017 and held it in 25 quarters. The position peaked at $22.5M in Q4 2021. 316 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Trillium Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Trillium Asset Management sold 89,416 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $3.51M.
  • Trillium Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 25 quarters.
  • Trillium Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $22.5M in Q4 2021.
  • 316 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Trillium Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.